NYSE : TAK

Takeda Pharmaceutical Company Limited

$16.73 USD

$0.28 (1.7%)

Volume
5.85M
Average Volume
2.95M
Market Capitalization
$53.22B
P/E Ratio
44.48
Dividend Yield
3.69%
Price Target
Year High
$18.90
Year Low
$12.99
Day High
—
Day Low
—
Payout Ratio
$1.63
Current Ratio
$1.27

TAK Estimated and Actual Revenue by Quarter

TAK Estimated and Actual EPS by Quarter

TAK Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-03-31 2 315.64B 342.31B 329.74B 143.8B 155.95B 150.23B
2027-12-31 3 330.9B 358.85B 345.68B 150.75B 163.49B 157.49B
2027-09-30 2 331.18B 359.16B 345.98B 150.88B 163.63B 157.62B
2027-06-30 2 323.75B 351.09B 338.21B 147.49B 159.95B 154.08B
2027-03-31 3 325.21B 352.68B 339.73B 148.16B 160.67B 154.78B
2026-12-31 3 338.54B 367.14B 353.67B 154.24B 167.26B 161.13B
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-03-31 2 147.65B 164.09B 156.35B 261.23B 283.3B 272.9B
2027-12-31 3 195.84B 217.63B 207.36B 273.86B 297B 286.1B
2027-09-30 2 242.46B 269.45B 256.73B 274.1B 297.25B 286.34B
2027-06-30 2 101.34B 112.62B 107.3B 267.94B 290.57B 279.91B
2027-03-31 3 -31.8B -28.61B -30.3B 269.15B 291.89B 281.17B
2026-12-31 3 76.9B 85.46B 81.43B 280.19B 303.86B 292.71B
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-03-31 2 1.07T 1.16T 1.11T 1 47.24961 52.50881 50.03076
2027-12-31 3 1.12T 1.21T 1.17T 1 62.66782 69.64318 66.3565
2027-09-30 2 1.12T 1.21T 1.17T 1 77.58868 86.22484 82.15562
2027-06-30 2 1.09T 1.19T 1.14T 1 32.42811 36.03759 34.33686
2027-03-31 3 1.1T 1.19T 1.15T 1 -10.17513 -9.156 -9.69493
2026-12-31 3 1.14T 1.24T 1.19T 1 24.60927 27.34845 26.05779